1014 / 1851
Overall survival
RTOG 0617 vs RADITUX
Raditux trial
RTOG 0617
60 Gy
RTOG 0617
74 Gy
Mortality
64%*
58%
a
67%
a
1-year OS (%)
75%
78%
69%
2-year OS (%)
60%
53%
42%
5-year OS (%)
37%
-
-
Median OS (months)
32 months
29 months
20 months
*based on 5-years of follow-up
a
based on 2-years of follow-up